Kura Oncology, Inc. (KURA) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "KURA"
      ],
      "issuer_cik": "0001422143",
      "owner_cik": "0002051106",
      "accession_number": "0001193125-26-407937",
      "form_type": "4",
      "filing_date": "2026-09-29",
      "period_of_report": "2026-09-28",
      "issuer_name": "Kura Oncology, Inc.",
      "issuer_trading_symbol": "KURA",
      "owner_name": "Leoni Mollie",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Medical Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-29",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 28802,
      "transaction_price_per_share": 10.7481,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 141095,
      "transaction_value": 309566.7762,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F2",
          "description": "The shares sold were acquired by the Reporting Person upon vesting of performance restricted stock units on September 27, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026."
        },
        {
          "id": "F3",
          "description": "This transaction was executed in multiple trades at prices ranging from $10.53 to $10.89. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
        }
      ]
    },
    {
      "tickers": [
        "KURA"
      ],
      "issuer_cik": "0001422143",
      "owner_cik": "0001934232",
      "accession_number": "0001193125-26-407935",
      "form_type": "4",
      "filing_date": "2026-09-29",
      "period_of_report": "2026-09-28",
      "issuer_name": "Kura Oncology, Inc.",
      "issuer_trading_symbol": "KURA",
      "owner_name": "Powl Brian T.",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Commercial Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-28",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 8000,
      "transaction_price_per_share": 10.5622,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 152249,
      "transaction_value": 84497.6,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F2",
          "description": "The shares sold were acquired by the Reporting Person upon vesting of restricted stock units on September 27, 2025. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."
        },
        {
          "id": "F3",
          "description": "This transaction was executed in multiple trades at prices ranging from $10.40 to $10.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.